Comparison

Ipamorelin vs MK-677

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

Ipamorelin

Also: IPAM, NNC 26-0161

Clinical Trials

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.

Growth HormoneHuman Trials
MK-677

Also: Ibutamoren, Nutrobal

Clinical Trials

An orally active growth hormone secretagogue that mimics ghrelin. Not a peptide technically, but frequently discussed alongside GH peptides due to similar effects.

Growth HormoneHuman Trials

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.

Detailed Comparison

AttributeIpamorelinMK-677
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionIpamorelin binds to ghrelin receptors (GHSR) in the pituitary gland, triggering growth hormone release. Unlike other GHRPs, it does not stimulate significant ACTH, cortisol, prolactin, or aldosterone release, making it highly selective for GH.MK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it's orally bioavailable and has a long half-life providing 24-hour GH elevation.
Common Dosing
200-300 mcg 2-3x daily
2-3x daily
10-25 mg daily
Once daily, often before bed
AdministrationSubcutaneous injectionOral
Typical Duration8-12 weeks typical8-12 weeks or longer
Best Time to TakeBefore bed or morning (fasted)Before bed
Possible Side Effects
May vary by individual
  • Generally well-tolerated
  • Injection site reactions
  • Headache
  • Nausea
  • Increased appetite
  • +4 more
  • Increased appetite and hunger
  • Weight gain
  • Water retention
  • Insulin resistance
  • Elevated blood glucose
  • +3 more
Research SummaryClinical studies show dose-dependent GH release with minimal side effects. Research demonstrates improved bone density in postmenopausal women and potential benefits for muscle mass and recovery. Has been studied for post-surgical recovery.Studies show significant increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. Research in elderly shows reversal of diet-induced nitrogen wasting. Long-term studies demonstrate sustained efficacy.

Frequently Asked Questions: Ipamorelin vs MK-677

What is the difference between Ipamorelin and MK-677?

Ipamorelin is a growth hormone peptide that a selective growth hormone secretagogue that stimulates gh release without significantly affecting cortisol or prolactin. considered one of the safest ghrps. MK-677 is a growth hormone peptide that an orally active growth hormone secretagogue that mimics ghrelin. not a peptide technically, but frequently discussed alongside gh peptides due to similar effects. The main differences lie in their mechanisms of action and clinical applications.

Which is better, Ipamorelin or MK-677?

Neither is universally "better" - the choice depends on your specific goals. Ipamorelin is typically used for growth hormone purposes, while MK-677 is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can Ipamorelin and MK-677 be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using Ipamorelin and MK-677 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of Ipamorelin and MK-677 is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.